FDA notification: thrombosis and hypersensitivity with Cypher stent

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1412, 2003-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel: Hypersensitivity leading to recurrent coronary stent thrombosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1366, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Sirolimus: Restenosis with a Cypher stent: case report

By  

Reactions Weekly, Vol. 1, Iss. 1252, 2009-01 ,pp. : 38-38

Adis International

Access to resources Recommend Favorite

Antiplatelets/iopromide/sirolimus: Hypersensitivity and stent thrombosis manifesting as Kounis syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1314, 2010-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Cordis Corporation has announced the launch of its third-generation sirolimus-eluting coronary stent, Cypher Select Plus.

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Pathobiology of Stent Thrombosis after Drug-Eluting Stent Implantation

By  

Current Pharmaceutical Design, Vol. 16, Iss. 36, 2010-12 ,pp. : 4064-4071

Bentham Science Publishers

Access to resources Recommend Favorite